Sfrp5 expression and secretion in adipocytes are up-regulated during differentiation and are negatively correlated with insulin resistance

被引:38
作者
Lv, Ci [1 ]
Jiang, Youzhao [1 ]
Wang, Hui [1 ]
Chen, Bing [1 ]
机构
[1] Third Mil Med Univ, Southwest Hosp, Dept Endocrinol, Chongqing 400038, Peoples R China
关键词
adipogenesis; insulin resistance; obese; Sfrp5; 3T3-L1; pre-adipocytes; TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; INFLAMMATION; CONTRIBUTES; METFORMIN; GLUCONEOGENESIS; MACROPHAGES; APOPTOSIS; ADIPOKINE; GLUCOSE;
D O I
10.1042/CBI20120054
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have examined the patterns of Sfrp5 (secreted frizzled-related protein 5) mRNA expression and protein secretion during adipocyte differentiation, and investigated the potential role of Sfrp5 in IR (insulin resistance) in adipocytes. 3T3-L1 pre-adipocytes were induced for differentiation, and RT-PCR (reverse transcription-PCR) and ELISA assays were used to determine Sfrp5 mRNA expression and protein secretion. The results showed that with the differentiation and maturity of pre-adipocytes, transcription and protein secretion of Sfrp5 gradually increased, peaking on the 9th day of differentiation. Sfrp5 mRNA expression in mature adipocytes was decreased by 20, 22 and 32 upon treatment with dexamethasone, insulin and TNF (tumour necrosis factor) respectively, whereas Sfrp5 protein secretion was decreased by 15, 17 and 30%, correspondingly. In contrast, Sfrp5 mRNA expression in mature adipose was increased by 34 and 19% upon treatment with rosiglitazone and metformin respectively, whereas Sfrp5 protein secretion was increased by 10 and 6%, correspondingly. In conclusion, Sfrp5 mRNA expression and protein secretion depend on the differentiation of adipocytes. The dysregulation of Sfrp5 expression and secretion is directly correlated with IR. Up-regulation of Sfrp5 expression and secretion in adipocytes may be one crucial mechanism by which rosiglitazone and metformin improve insulin sensitivity.
引用
收藏
页码:851 / 855
页数:5
相关论文
共 31 条
[1]   CELLULAR AND MOLECULAR ASPECTS OF ADIPOSE-TISSUE DEVELOPMENT [J].
AILHAUD, G ;
GRIMALDI, P ;
NEGREL, R .
ANNUAL REVIEW OF NUTRITION, 1992, 12 :207-233
[2]   Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels [J].
Anedda, Andrea ;
Rial, Eduardo ;
Gonzalez-Barroso, M. Mar .
JOURNAL OF ENDOCRINOLOGY, 2008, 199 (01) :33-40
[3]   Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes [J].
Boden, G ;
Cheung, P ;
Mozzoli, M ;
Fried, SK .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (06) :753-759
[4]   Regulation of adipocyte differentiation and insulin action with rapamycin [J].
Cho, HJ ;
Park, J ;
Lee, HW ;
Lee, YS ;
Kim, JB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (04) :942-948
[5]   Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition [J].
Grundy, SM ;
Brewer, HB ;
Cleeman, JI ;
Smith, SC ;
Lenfant, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (02) :E13-E18
[6]   Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes [J].
Gustafson, B ;
Smith, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (14) :9507-9516
[7]   Wnt-signaling is maintained and adipogenesis inhibited by TNFα but not MCP-1 and resistin [J].
Hammarstedt, Ann ;
Isakson, Petter ;
Gustafson, Birgit ;
Smith, Ulf .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 357 (03) :700-706
[8]  
He B, 2005, CANCER RES, V65, P743
[9]   Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein [J].
He, Ling ;
Sabet, Amin ;
Djedjos, Stephen ;
Miller, Ryan ;
Sun, Xiaojian ;
Hussain, Mehboob A. ;
Radovick, Sally ;
Wondisford, Fredric E. .
CELL, 2009, 137 (04) :635-646
[10]   Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity [J].
Heilbronn, Leonie K. ;
Campbell, Lesley V. .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (12) :1225-1230